| Abstrakt: |
Keywords: Amino Acids; Aromatic Amino Acids; Asymptomatic Infection; Biotechnology Companies; Business; COVID-19; Coronaviridae; Coronavirus; Cytokines; Drugs and Therapies; Enzymes and Coenzymes; Epidemiology; Health and Medicine; Hospitals; Immunology; Inflammation; Intercellular Signaling Peptides and Proteins; Interferons; Interleukins; Kinase; Mortality; Nidovirales; Pfizer Inc.; Pharmaceutical Companies; Proteins; Proteomics; RNA Viruses; Risk and Prevention; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Therapeutics; Therapy; Tyrosine; Tyrosine Kinase; Viral; Virology; Virus EN Amino Acids Aromatic Amino Acids Asymptomatic Infection Biotechnology Companies Business COVID-19 Coronaviridae Coronavirus Cytokines Drugs and Therapies Enzymes and Coenzymes Epidemiology Health and Medicine Hospitals Immunology Inflammation Intercellular Signaling Peptides and Proteins Interferons Interleukins Kinase Mortality Nidovirales Pfizer Inc. Pharmaceutical Companies Proteins Proteomics RNA Viruses Risk and Prevention SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Therapeutics Therapy Tyrosine Tyrosine Kinase Viral Virology Virus 2614 2614 1 06/05/23 20230606 NES 230606 2023 JUN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- A patent application by the inventors Corbo, Michael (Flemington, NJ, US); Danto, Spencer Ian (Sharon, MA, US); Koncz, Tamas Andras (New York, NY, US); Peeva, Elena (Tarrytown, NY, US); Valdez, V, Hernan (New York, NY, US); Vincent, Michael Steven (Newton, MA, US); Williams, Cara Margaret May (Beverly, MA, US), filed on April 1, 2021, was made available online on May 18, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. [Extracted from the article] |
